Lmr Partners LLP Ultragenyx Pharmaceutical Inc. Transaction History
Lmr Partners LLP
- $9.66 Billion
- Q4 2024
A detailed history of Lmr Partners LLP transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Lmr Partners LLP holds 130,100 shares of RARE stock, worth $5.06 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
130,100
Previous 30,000
333.67%
Holding current value
$5.06 Million
Previous $1.67 Million
228.51%
% of portfolio
0.06%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding RARE
# of Institutions
344Shares Held
84.3MCall Options Held
675KPut Options Held
846K-
Vanguard Group Inc Valley Forge, PA10MShares$390 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$218 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA4.3MShares$167 Million0.57% of portfolio
-
State Street Corp Boston, MA2.72MShares$106 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.51MShares$97.7 Million0.01% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.72B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...